Direkt zum Inhalt
Merck

Keratocystic odontogenic tumor. Case report and review of the literature.

The New York state dental journal (2013-05-23)
Mariano Sanchez-Siles, Fabio Camacho-Alonso, Pia Lopez-Jornet, Noemi Salazar-Sanchez
ZUSAMMENFASSUNG

Keratocystic odontogenic tumor is an intraosseous benign tumor of epithelial origin that can appear as a unicystic or multicystic lesion. It is characterized most significantly by its high recurrence rate. This is why surgical removal is the chosen therapeutic approach in most cases. However, while surgery may be the safest technique to prevent recidivism, it may also result in numerous complications with large tumors. A number of authors have suggested a more conservative treatment for large keratocystic odontogenic tumors. The case examined in this article is that of a 48-year-old male patient who presented with a five-month swelling on the left side of his face, located in the mandibular area.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Chlorhexidin, ≥99.5%
Sigma-Aldrich
Keratin aus Humanepidermis, aqueous solution
Sigma-Aldrich
Chlorhexidin -dihydrochlorid, ≥98%
Chlorhexidin, European Pharmacopoeia (EP) Reference Standard
Chlorhexidin -dihydrochlorid, European Pharmacopoeia (EP) Reference Standard